SSSophie Strachan

Sophie Strachan

*This is an algorithmically generated author record based on publicly available information.

Sophie Strachan has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of the psychometric properties of the Episodic Disability Questionnaire (EDQ) among women living with HIV in the United Kingdom: a self-reported repeated measure study

    by DA Brown Obe, Shema Tariq, Marta Boffito, David Asboe, Ana Milinkovic, Nneka Nwokolo, Carol Flavell, Sophie Strachan, Lisa Avery, Kelly K O'Brien, et al.

    Background: Disability is an increasingly common health outcome as women age with HIV and multimorbidity. The Episodic Disability Questionnaire (EDQ) measures the presence, severity, and episodic nature of disability across six domains. We evaluated EDQ properties among women living with HIV in the United Kingdom. Methods: Participants in the Positive Transitions Through the Menopause (PRIME) study completed the EDQ at two timepoints (1 week apart), criterion measures (WHODAS 2.0, EQ-5D-5L, Work and Social Adjustment Scale), and a demographic questionnaire. We evaluated internal consistency (Cronbach alpha ≥0.7), test-retest reliability (ICC >0.7), measurement precision (Minimum Detectable Change (MDC) 95%), and construct validity (≥75% a priori hypotheses met). Disability prevalence was assessed using WHODAS 2.0 (moderate threshold) and Equality Act Disability Definition (severe threshold). Results: Of 104 participants (median age 56 years, 65% Black ethnicity), 93 (89%) completed the EDQ twice. Median duration since HIV diagnosis was 23 years; 98% had undetectable viral loads and 86% reported multimorbidity. Cronbach’s alpha ranged from 0.83 (social domain) to 0.92 (daily activities domain). ICC ranged from 0.70 (physical domain) to 0.91 (daily activities domain). Precision was highest in daily activities domain (MDC95%: 6.10) and lowest in mental-emotional domain (MDC95%: 11.52). Eighty percent (n=47/59) of construct validity hypotheses were met. Disability prevalence was 79.81% (95%CI 70.57, 86.79) moderate and 41.75% (32.24, 51.88) severe disability. Conclusions: The EDQ possesses internal consistency, test-retest reliability, and construct validity with varied precision among women living with HIV. Results can support research and clinical practice to measure disability and evaluate interventions.

  • Late diagnosis of HIV in 2022: Why so little change?

    by Simon Collins, Angelina Namiba, Alex Sparrowhawk, Sophie Strachan, Marc Thompson, Hideta Nakamura

    Background: The proportion of people who are diagnosed late is a key metric to measure the public health response to HIV. But this percentage remains stubbornly high in nearly every country. Delays in accessing antiretroviral therapy affects both (i) individual health, due to a higher risk of mortality, and (ii) population‐based health, due to continued risk of transmission. Despite huge efforts to increase testing, late diagnosis continues to be an indication of a public health failure.Outline: This short review includes community perspectives on why late diagnosis continues and how it may be reduced. We discuss both structural barriers that prevent people from testing earlier and personal reasons why some people still refuse testing when offered. We note that late diagnosis is reported in all countries and in all demographic groups and that sex, gender, age, and sexuality all affect these rates. However, even in groups with high HIV awareness, such as in gay and bisexual men in the UK, more than one in three people with HIV continue to be diagnosed late. Fears and prejudice about HIV based on outdated information are still common among both health workers and people using health services. For example, testing is still not offered in primary or emergency care settings, and even free testing might not be accepted if someone fears the outcome might jeopardize their resident status, employment, relationship, or health.Summary: In addition to developing targeted projects to reach the highest‐risk groups, a positive mainstream public campaign could make testing more acceptable at a broad population level across all demographics. This could challenge and repair the media campaigns from the 1980s that still contribute to the stigma that frightens people away from testing now. We hope that an effective approach in one country might also help others.


  • Open Access

    Public understanding and awareness of and response to monkeypox virus outbreak: A cross‐sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency

    by Sara Paparini, Ryan Whitacre, Melanie Smuk, John Thornhill, Chikondi Mwendera, Sophie Strachan, Will Nutland, Chloe Orkin

    Objectives: Our objective was to examine the public response to public health and media messaging during the human monkeypox virus (MPXV) outbreak in the UK, focusing on at‐risk communities.Methods: A co‐produced, cross‐sectional survey was administered in June and July 2022 using community social media channels and the Grindr dating app. Basic descriptive statistics, logistic regression, and odds ratio p values are presented.Results: Of 1932 survey respondents, 1750 identified as men, 88 as women, and 64 as gender non‐conforming. Sexual identity was described as gay/lesbian/queer (80%), bisexual (12%), heterosexual (4%), and pansexual (2%); 39% were aged <40 years; 71% self‐identified as White, 3% as Black, 8% as Asian, 2%as LatinX, and 11% as ‘Mixed or Other’ heritage groups. In total, 85% were employed and 79% had completed higher education. A total of 7% of respondents identified themselves as living with HIV. Overall, 34% reported limited understanding of public health information, 52% considered themselves at risk, 61% agreed that people with MPXV should isolate for 21 days, 49% reported they would first attend a sexual health clinic if symptomatic, 86% reported they would accept a vaccine, and 59% believed that MPXV originated from animals. The most trusted sources of information were healthcare professionals (37%), official health agencies (29%), and mainstream media (12%).Conclusions: Vaccine acceptability was very high, yet the understanding and acceptance of public health information varied. Social determinants of health inequalities already shaping the UK landscape risk were compounded in this new emergency. Engagement with structurally disadvantaged members of affected communities and better dissemination of public health messaging by trusted healthcare professionals are essential for the public health response.


  • Open Access

    Public understanding, awareness, and response to monkeypox virus outbreak: A cross-sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency

    by Sara Paparini, Ryan Whitacre, Melanie Smuk, John Thornhill, Chikondi Mwendera, Sophie Strachan, Will Nutland, Chloe Orkin

    Objectives To examine awareness, understanding, and response to the monkeypox (MPXV) outbreak among the most affected communities in the United Kingdom. Methods A cross-sectional survey was administered between June 15 and July 27, 2022, targeting adults using LGBTQI community channels on social media platforms and the dating app, Grindr. Basic descriptive statistics have been created and logistic regression implemented to explore associations. Odds ratio p values have been given for completeness. No formal power calculation was implemented. Results 1932 respondents completed the survey, 1691 (90%) were cis or trans men who have sex with men. 1750/1932 identified as men, 88 as women and 64 as gender non-conforming. 1453 (77%) described their sexual identity as gay/ lesbian, 64 (3%) as queer, 221 as bisexual (12%), 81 (4%) as heterosexual, 37 (2%) as pansexual. 744 (39%) were under the age of 40. 71% (1366) self-identified as being from White, 3% (67) Black, 8% Asian (158), 2% LatinX(36) and 11% (203) ‘Mixed or Other’ heritage groups. 85% were employed and 79% had completed higher education. 137 (7%) identified themselves as living with HIV when asked if they lived with a long-term condition. Overall, 34% reported a limited understanding of public health information, 52% considered themselves at risk, 61% agreed people infected with MPXV should isolate for 21 days, 49% reported they would first attend a sexual health clinic if infected, 86% reported they would accept a vaccine and 59% believed MPXV originated from animals. Reported level of understanding of public health information, agreement to the need to isolate for 21 days, vaccine acceptance, and beliefs about the origins of MPXV varied by income level, education and heritage. Trust in healthcare providers, perception of risk of MPXV, and willingness to be vaccinated differed by gender and sexual identity. The most trusted sources of information were healthcare professionals (37%), official health agencies (29%), and mainstream media (12%). Younger participants were most likely to state they would not engage with clinical services if they had MPXV symptoms. Conclusions In this group of respondents, largely made up of White, male, employed men who have sex with men with university education, vaccine acceptability was very high, yet public health information and advice were neither universally accepted nor correctly understood. Social determinants of health inequalities already shaping the UK public health landscape are at risk of being compounded in this new emergency. Engagement with structurally disadvantaged members of affected communities is essential for the public health response. Further research is needed to establish awareness, risk perception, engagement in care, and vaccine acceptability, especially in more diverse and vulnerable populations.


  • Open Access

    What will it take to achieve the sexual and reproductive health and rights of women living with HIV?

    by Keren Dunaway, Sophie Brion, Fiona Hale, Jacquelyne Alesi, Happy Assan, Cecilia Chung, Svitlana Moroz, Angelina Namiba, Joyce Ouma, Immaculate B Owomugisha, et al.

    This article outlines progress in realizing the sexual and reproductive health and rights of women and girls living with HIV over the last 30 years from the perspective of women living with HIV. It argues that the HIV response needs to go beyond the bio-medical aspects of HIV to achieve our sexual and reproductive health and rights, and considers relevant Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization, United States President’s Emergency Plan for AIDS Relief (PEPFAR), Global Fund and other guidelines, what engagement there has been with women living with HIV and whether guidelines/strategies have been adopted. It has been written by women living with HIV from around the world and a few key supporters. Co-authors have sought to collate and cite materials produced by women living with HIV from around the world, in the first known effort to date to do this, as a convergence of evidence to substantiate the points made in the article. However, as the article also argues, research led by women living with HIV is seldom funded and rarely accepted as evidence. Combined with a lack of meaningful involvement of women living with HIV in others’ research on us, this means that formally recognized evidence from women’s own perspectives is patchy at best. The article argues that this research gap, combined with the ongoing primacy of conventional research methods and topics that exclude those most affected by issues, and the lack of political will (and sometimes outright opposition) in relation to gender equality and human rights, adversely affect policies and programmes in relation to women’s rights. Thus, efforts to achieve an ethical, effective and sustainable response to the pandemic are hindered. The article concludes with a call to action to all key stakeholders.


  • Open Access

    Time to realise our sexual and reproductive health and rights

    by Florence Anam, Cecilia Chung, Sophie Dilmitis, Calorine Kenkem, Rebecca Matheson-Omondi, Svitlana Moroz, Lillian Mworeko, Hajjarah Nagadya, Angelina Namiba, Violeta Ross, et al.